Annual report
4088.TEDINET S100YTH5
Period2021-04-01 → 2022-03-31
Filed2026-07-31
StandardIFRS
ConsolidatedYes
Data checks21 of 22 passed
Amends S100OIFT. Amended by S100YTKF (2026-07-31).
Key figures · 187
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥846.8bn | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥767.2bn | 2020-04-01 → 2021-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥814.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥765.4bn | 2019-04-01 → 2020-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥801.5bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥742.3bn | 2018-04-01 → 2019-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥753.6bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥62.5bn | 2021-04-01 → 2022-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥47.8bn | 2020-04-01 → 2021-03-31 | Cons. | Operating profit loss IFRS |
| Ordinary income | ¥45.2bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥47.0bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥44.7bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥61.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥45.8bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥40.8bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥42.1bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥41.7bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥23.9bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥16.7bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥22.8bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥26.5bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥28.8bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥25.2bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥44.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥26.6bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥25.4bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥30.1bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss IFRS (5-year summary) |
| Total assets | ¥1.04T | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥966.3bn | at 2021-03-31 | Cons. | Assets IFRS |
| Total assets | ¥889.2bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥927.6bn | at 2020-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥783.0bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥785.9bn | at 2019-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥693.1bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥694.9bn | at 2018-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥653.2bn | at 2022-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥619.6bn | at 2021-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥389.5bn | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥346.6bn | at 2021-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥329.1bn | at 2020-03-31d | Cons. | Equity IFRS |
| Net assets / equity | ¥363.8bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥308.7bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥294.6bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Equity (owners) | ¥364.6bn | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥329.7bn | at 2021-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥308.6bn | at 2020-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥278.1bn | at 2019-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥263.6bn | at 2018-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥62.7bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥50.1bn | at 2021-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥45.2bn | at 2020-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥41.4bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥31.5bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥32.1bn | at 2019-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥22.4bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥23.3bn | at 2018-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥75.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥82.2bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥40.0bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥37.3bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥56.7bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥61.2bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥47.8bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥57.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥66.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥113.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥117.8bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥88.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥91.6bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥61.6bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥6.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥12.1bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥82.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥91.9bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥40.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥39.0bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥4.5bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥184.22 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥105.46 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥81.05 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.26 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥135.34 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥147.33 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥128.95 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥184.02 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥105.34 | 2020-04-01 → 2021-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥80.93 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥110.09 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥135.09 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥147.06 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥128.72 | 2017-04-01 → 2018-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,609.85 | at 2022-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,460.22 | at 2021-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,503.42 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,357.12 | at 2020-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,487.58 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,420.37 | at 2019-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,422.6 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,349.1 | at 2018-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 35.0% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 34.1% | at 2021-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 38.4% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.3% | at 2020-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 37.2% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.4% | at 2019-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 40.1% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.9% | at 2018-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 12.0% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 7.5% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 5.3% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.0% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 9.3% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.6% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 9.4% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 19,299 | at 2022-03-31 | Cons. | Number of employees |
| Revenue | ¥139.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥118.6bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥129.2bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥177.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥167.8bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥5.2bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | −¥6.9bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥14.1bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥8.3bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥8.7bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥15.8bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥15.5bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥10.6bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥6.7bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥11.4bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥9.1bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | −¥2.8bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥12.9bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥11.9bn | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥523.4bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥499.3bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥485.3bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥424.9bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥376.7bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥328.7bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥296.1bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥194.7bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥203.2bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥200.6bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥170.8bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥168.4bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥18.6bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥13.5bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥50.19 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.2 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.35 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥66.1 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.73 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥50.14 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥40.15 | 2020-04-01 → 2021-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥65.98 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥60.62 | 2017-04-01 → 2018-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥56 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥44 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥44 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥38 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥858.08 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥898.66 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥880.75 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥870.14 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥859.95 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 37.1% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.6% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.3% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.1% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.6% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 5.7% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.5% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -1.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 229,755,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 229,755,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 229,755,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 198,705,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 198,705,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 666 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 853 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 909 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 856 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 1,007 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 133
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2021-04-01 → 2022-03-31 | ¥6.6bn |
| Otherother segments | employees | at 2022-03-31 | 2579 pure |
| Otherother segments | revenue | 2021-04-01 → 2022-03-31 | ¥148.8bn |
| Otherother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥145.7bn |
| Otherother segments | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥3.1bn |
| Otherother segments | segment assets | at 2022-03-31 | ¥191.5bn |
| Otherother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥8.7bn |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥3.3bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥37.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥37.1bn |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥122.7bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | ¥1.6bn |
| Agriculture And Food Productsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥8.2bn |
| Agriculture And Food Productsreportable segment | employees | at 2022-03-31 | 3346 pure |
| Agriculture And Food Productsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥116.7bn |
| Agriculture And Food Productsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥116.0bn |
| Agriculture And Food Productsreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥709m |
| Agriculture And Food Productsreportable segment | segment assets | at 2022-03-31 | ¥93.2bn |
| Agriculture And Food Productsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥5.4bn |
| Chemicalreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥4.2bn |
| Chemicalreportable segment | employees | at 2022-03-31 | 890 pure |
| Chemicalreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥39.2bn |
| Chemicalreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥38.9bn |
| Chemicalreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥351m |
| Chemicalreportable segment | segment assets | at 2022-03-31 | ¥48.8bn |
| Chemicalreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥3.4bn |
| Energyreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥3.7bn |
| Energyreportable segment | employees | at 2022-03-31 | 1052 pure |
| Energyreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥65.7bn |
| Energyreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥62.1bn |
| Energyreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥3.6bn |
| Energyreportable segment | segment assets | at 2022-03-31 | ¥36.8bn |
| Energyreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥4.4bn |
| Industrial Gasreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥12.0bn |
| Industrial Gasreportable segment | employees | at 2022-03-31 | 3004 pure |
| Industrial Gasreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥201.8bn |
| Industrial Gasreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥191.5bn |
| Industrial Gasreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥10.4bn |
| Industrial Gasreportable segment | segment assets | at 2022-03-31 | ¥277.0bn |
| Industrial Gasreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥21.4bn |
| Logisticsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥5.1bn |
| Logisticsreportable segment | employees | at 2022-03-31 | 2658 pure |
| Logisticsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥76.1bn |
| Logisticsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥58.2bn |
| Logisticsreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥17.8bn |
| Logisticsreportable segment | segment assets | at 2022-03-31 | ¥59.0bn |
| Logisticsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥3.1bn |
| Medicalreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥4.6bn |
| Medicalreportable segment | employees | at 2022-03-31 | 4495 pure |
| Medicalreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥189.6bn |
| Medicalreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥188.9bn |
| Medicalreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥747m |
| Medicalreportable segment | segment assets | at 2022-03-31 | ¥136.3bn |
| Medicalreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥11.6bn |
| Seawaterreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥8.4bn |
| Seawaterreportable segment | employees | at 2022-03-31 | 968 pure |
| Seawaterreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥46.0bn |
| Seawaterreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥45.5bn |
| Seawaterreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥519m |
| Seawaterreportable segment | segment assets | at 2022-03-31 | ¥77.3bn |
| Seawaterreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥2.8bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥53.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥883.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥846.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥37.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥919.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥60.8bn |
| Otherother segments | capex | 2020-04-01 → 2021-03-31 | ¥15.4bn |
| Otherother segments | revenue | 2020-04-01 → 2021-03-31 | ¥117.6bn |
| Otherother segments | revenue external | 2020-04-01 → 2021-03-31 | ¥114.7bn |
| Otherother segments | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥2.8bn |
| Otherother segments | segment assets | at 2021-03-31 | ¥185.1bn |
| Otherother segments | segment profit | 2020-04-01 → 2021-03-31 | ¥4.8bn |
| Reconciling Itemsreconciling | capex | 2020-04-01 → 2021-03-31 | ¥2.7bn |
| Reconciling Itemsreconciling | revenue | 2020-04-01 → 2021-03-31 | −¥30.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2020-04-01 → 2021-03-31 | −¥30.5bn |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥115.9bn |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2021-03-31 | −¥1.4bn |
| Agriculture And Food Productsreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥3.6bn |
| Agriculture And Food Productsreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥109.9bn |
| Agriculture And Food Productsreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥109.2bn |
| Agriculture And Food Productsreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥759m |
| Agriculture And Food Productsreportable segment | segment assets | at 2021-03-31 | ¥75.1bn |
| Agriculture And Food Productsreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥4.0bn |
| Chemicalreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥2.6bn |
| Chemicalreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥33.6bn |
| Chemicalreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥33.3bn |
| Chemicalreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥290m |
| Chemicalreportable segment | segment assets | at 2021-03-31 | ¥45.5bn |
| Chemicalreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥2.0bn |
| Energyreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥3.2bn |
| Energyreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥55.3bn |
| Energyreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥52.6bn |
| Energyreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥2.7bn |
| Energyreportable segment | segment assets | at 2021-03-31 | ¥32.6bn |
| Energyreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥4.5bn |
| Industrial Gasreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥18.2bn |
| Industrial Gasreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥190.3bn |
| Industrial Gasreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥183.9bn |
| Industrial Gasreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥6.4bn |
| Industrial Gasreportable segment | segment assets | at 2021-03-31 | ¥257.1bn |
| Industrial Gasreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥19.0bn |
| Logisticsreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥6.7bn |
| Logisticsreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥69.9bn |
| Logisticsreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥53.1bn |
| Logisticsreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥16.8bn |
| Logisticsreportable segment | segment assets | at 2021-03-31 | ¥52.6bn |
| Logisticsreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥2.8bn |
| Medicalreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥6.3bn |
| Medicalreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥180.5bn |
| Medicalreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥180.2bn |
| Medicalreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥357m |
| Medicalreportable segment | segment assets | at 2021-03-31 | ¥128.6bn |
| Medicalreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥9.6bn |
| Seawaterreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥9.6bn |
| Seawaterreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥40.6bn |
| Seawaterreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥40.2bn |
| Seawaterreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥421m |
| Seawaterreportable segment | segment assets | at 2021-03-31 | ¥73.8bn |
| Seawaterreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥65.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥797.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥767.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥30.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥850.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥49.2bn |
| Otherother segments | employees | at 2022-03-31 | 28 pure |
| Agriculture And Food Productsreportable segment | employees | at 2022-03-31 | 26 pure |
| Chemicalreportable segment | employees | at 2022-03-31 | 44 pure |
| Energyreportable segment | employees | at 2022-03-31 | 23 pure |
| Industrial Gasreportable segment | employees | at 2022-03-31 | 161 pure |
| Medicalreportable segment | employees | at 2022-03-31 | 66 pure |
| Seawaterreportable segment | employees | at 2022-03-31 | 11 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,738
| Item | Context | Value | Unit |
|---|---|---|---|
| Average number of temporary workers | CurrentYearInstant_CorporateSharedMember | 1 | |
| Number of employees | CurrentYearInstant | 19299 | |
| Average number of temporary workers | CurrentYearInstant | 6975 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 666 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 44.1 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 12.4 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 7398000 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00792-000IndustrialGasReportableSegmentsMember | 161 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00792-000ChemicalReportableSegmentsMember | 44 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00792-000MedicalReportableSegmentsMember | 66 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00792-000EnergyReportableSegmentsMember | 23 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00792-000AgricultureAndFoodProductsReportableSegmentsMember | 26 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00792-000LogisticsReportableSegmentsMember | － | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E00792-000SeawaterReportableSegmentsMember | 11 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_OtherReportableSegmentsMember | 28 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 307 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 666 | |
| Research and development expenses research and development activities | CurrentYearDuration | 5438000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00792-000IndustrialGasReportableSegmentsMember | 332000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00792-000ChemicalReportableSegmentsMember | 1493000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00792-000MedicalReportableSegmentsMember | 1304000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00792-000EnergyReportableSegmentsMember | 179000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00792-000AgricultureAndFoodProductsReportableSegmentsMember | 458000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00792-000LogisticsReportableSegmentsMember | 30000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00792-000SeawaterReportableSegmentsMember | 363000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_OtherReportableSegmentsMember | 1275000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 56272000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00792-000IndustrialGasReportableSegmentsMember | 12046000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00792-000ChemicalReportableSegmentsMember | 4241000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00792-000MedicalReportableSegmentsMember | 4610000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00792-000EnergyReportableSegmentsMember | 3725000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00792-000AgricultureAndFoodProductsReportableSegmentsMember | 8242000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00792-000LogisticsReportableSegmentsMember | 5123000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00792-000SeawaterReportableSegmentsMember | 8440000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_OtherReportableSegmentsMember | 6580000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_CorporateSharedMember | 3263000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 229755057 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 229755057 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 229755057 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 229755057 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 93 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 41 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 481 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 293 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 22 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 20319 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 21249 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 22 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | mismatch |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |